Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 25

    1.

    Prostate cancer risk and vitamin E.

    Hoskote SS, Nadkarni GN, Fried ED.

    JAMA. 2012 Feb 1;307(5):454; author reply 454. No abstract available.

    PMID:
    22298668
    [PubMed - indexed for MEDLINE]
    2.

    Prostate cancer risk and vitamin E.

    Gaby AR.

    JAMA. 2012 Feb 1;307(5):453-4; author reply 454. No abstract available.

    PMID:
    22298667
    [PubMed - indexed for MEDLINE]
    3.

    Screening for osteoporosis in men receiving androgen deprivation therapy.

    Alibhai SM, Yun L, Cheung AM, Paszat L.

    JAMA. 2012 Jan 18;307(3):255-6. No abstract available.

    PMID:
    22253389
    [PubMed - indexed for MEDLINE]
    4.

    Expert panel advocates surveillance for men with low-risk prostate cancer.

    Slomski A.

    JAMA. 2012 Jan 11;307(2):133. No abstract available.

    PMID:
    22235075
    [PubMed - indexed for MEDLINE]
    5.

    Prostate cancer screening--the evidence, the recommendations, and the clinical implications.

    Chou R, LeFevre ML.

    JAMA. 2011 Dec 28;306(24):2721-2. No abstract available.

    PMID:
    22203543
    [PubMed - indexed for MEDLINE]
    6.

    Missing the mark on prostate-specific antigen screening.

    Miller DC, Hollenbeck BK.

    JAMA. 2011 Dec 28;306(24):2719-20. No abstract available.

    PMID:
    22203542
    [PubMed - indexed for MEDLINE]
    7.

    Prostate cancer screening--time to abandon one-size-fits-all approach?

    Kim J, Davis JW.

    JAMA. 2011 Dec 28;306(24):2717-8. No abstract available.

    PMID:
    22203541
    [PubMed - indexed for MEDLINE]
    8.

    Grading the new US Preventive Services Task Force prostate cancer screening recommendation.

    Volk RJ, Wolf AM.

    JAMA. 2011 Dec 28;306(24):2715-6. No abstract available.

    PMID:
    22203540
    [PubMed - indexed for MEDLINE]
    9.

    A piece of my mind. Making the call.

    Welch HG.

    JAMA. 2011 Dec 28;306(24):2649-50. No abstract available.

    PMID:
    22203530
    [PubMed - indexed for MEDLINE]
    10.

    USPSTF finds little evidence to support advising PSA screening in any man.

    Slomski A.

    JAMA. 2011 Dec 21;306(23):2549-51. No abstract available.

    PMID:
    22187266
    [PubMed - indexed for MEDLINE]
    11.

    Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials.

    Nguyen PL, Je Y, Schutz FA, Hoffman KE, Hu JC, Parekh A, Beckman JA, Choueiri TK.

    JAMA. 2011 Dec 7;306(21):2359-66.

    PMID:
    22147380
    [PubMed - indexed for MEDLINE]
    12.

    Androgen deprivation therapy and competing risks.

    Kelly WK, Gomella LG.

    JAMA. 2011 Dec 7;306(21):2382-3. No abstract available.

    PMID:
    22147384
    [PubMed - indexed for MEDLINE]
    13.

    Narrative vs evidence-based medicine--and, not or.

    Meisel ZF, Karlawish J.

    JAMA. 2011 Nov 9;306(18):2022-3. No abstract available.

    PMID:
    22068995
    [PubMed - indexed for MEDLINE]
    14.

    Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

    Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman SM, Goodman GE, Meyskens FL Jr, Baker LH.

    JAMA. 2011 Oct 12;306(14):1549-56.

    PMID:
    21990298
    [PubMed - indexed for MEDLINE]
    15.

    Prediction of erectile function following treatment for prostate cancer.

    Alemozaffar M, Regan MM, Cooperberg MR, Wei JT, Michalski JM, Sandler HM, Hembroff L, Sadetsky N, Saigal CS, Litwin MS, Klein E, Kibel AS, Hamstra DA, Pisters LL, Kuban DA, Kaplan ID, Wood DP, Ciezki J, Dunn RL, Carroll PR, Sanda MG.

    JAMA. 2011 Sep 21;306(11):1205-14.

    PMID:
    21934053
    [PubMed - indexed for MEDLINE]
    16.

    Helping patients make better personal health decisions: the promise of patient-centered outcomes research.

    Barry MJ.

    JAMA. 2011 Sep 21;306(11):1258-9. No abstract available.

    PMID:
    21934062
    [PubMed - indexed for MEDLINE]
    17.

    Recording, interpreting, and updating the family history of cancer: implications for cancer prevention.

    Acheson LS.

    JAMA. 2011 Jul 13;306(2):208-10. No abstract available.

    PMID:
    21750302
    [PubMed - indexed for MEDLINE]
    18.

    Clinically relevant changes in family history of cancer over time.

    Ziogas A, Horick NK, Kinney AY, Lowery JT, Domchek SM, Isaacs C, Griffin CA, Moorman PG, Edwards KL, Hill DA, Berg JS, Tomlinson GE, Anton-Culver H, Strong LC, Kasten CH, Finkelstein DM, Plon SE.

    JAMA. 2011 Jul 13;306(2):172-8.

    PMID:
    21750294
    [PubMed - indexed for MEDLINE]
    19.

    Smoking and prostate cancer survival and recurrence.

    Kenfield SA, Stampfer MJ, Chan JM, Giovannucci E.

    JAMA. 2011 Jun 22;305(24):2548-55.

    PMID:
    21693743
    [PubMed - indexed for MEDLINE]
    20.

    Realigning incentives for developing and pricing new anticancer treatments.

    Howard DH.

    JAMA. 2011 Jun 8;305(22):2347-8. No abstract available.

    PMID:
    21642689
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk